LENSAR Q2 revenue up 10% to $13.9M; ALLY placements surge; Alcon merger on track

LENSAR, Inc.

2025-Q2 EPS reported -$2.46 revenue$28,094,000

Q2 2025 revenue $13.9M (+10% YoY); procedure volume up 23% to 52,100.
18 ALLY systems placed; ALLY installed base grew 107% to ~165; total installed base ~410 (+23% YoY).
Net loss improved to $1.8M ($0.15/share) from $9.0M ($0.79/share) in Q2 2024, driven by warrant liability change.
Adjusted EBITDA loss of $0.3M vs. $30K positive in prior year period.
Merger with Alcon received >99% shareholder approval; FTC review ongoing; expected close by year-end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.